<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="activity_corpus\PMC7830555\results\search\activity\results.xml">
  <result pre="italic;} MoleculesMoleculesmoleculesMolecules1420-3049MDPI pmcid: 7830555 pmid: 33477259 doi: 10.3390/molecules26020461molecules-26-00461 : Article" exact="Antifungal" post="Activity of Melaleuca alternifolia Essential Oil (TTO) and Its"/>
  <result pre="antifungals. The purpose of this study was to evaluate the" exact="antifungal" post="activity of tea tree oil (TTO) (Melaleuca alternifolia essential"/>
  <result pre="TTO in association with KTZ/ITZ as reference drugs improves the" exact="antifungal" post="activity of these drugs. We used a terpinen-4-ol chemotype"/>
  <result pre="drugs. We used a terpinen-4-ol chemotype (35.88%) TTO, and its" exact="antifungal" post="properties were evaluated by minimum inhibitory and minimum fungicidal"/>
  <result pre="the checkerboard and isobologram methods. The results demonstrated both the" exact="fungicide" post="activity of TTO on T. rubrum and the synergism"/>
  <result pre="checkerboard synergism 1. Introduction Dermatophytes are the most common fungal" exact="agents" post="leading to superficial skin infections. During the last century,"/>
  <result pre="terbinafine) (Figure 1) are the most important oral and topical" exact="antifungal" post="drugs used to treat dermatophytosis: they interfere with the"/>
  <result pre="lesions. However, inappropriate prescribing, and the increased use of systemic" exact="antifungal" post="agents in recent years are the main factors leading"/>
  <result pre="However, inappropriate prescribing, and the increased use of systemic antifungal" exact="agents" post="in recent years are the main factors leading to"/>
  <result pre="the main factors leading to the emergence of resistance to" exact="antifungal" post="drugs (i.e., azoles) [6]. In fact, if not properly"/>
  <result pre="if not properly treated, dermatophytosis may become chronic, requiring oral" exact="antifungal" post="drugs, which are often associated with side effects such"/>
  <result pre="been increasingly used in recent years for their biological and" exact="antimicrobial" post="activities. Furthermore, a recent focus of research on essential"/>
  <result pre="is to investigate their potential use in combination with conventional" exact="antimicrobial" post="drugs [8,9]. In fact, essential oils are one of"/>
  <result pre="sources for pharmacological research and the development of new natural" exact="antimicrobial" post="agents against many microbial pathogens such as bacteria, yeasts,"/>
  <result pre="for pharmacological research and the development of new natural antimicrobial" exact="agents" post="against many microbial pathogens such as bacteria, yeasts, filamentous"/>
  <result pre="essential oil of Melaleuca alternifolia (Myrtaceae), often used as an" exact="antiseptic" post="to treat skin infections, has recently received much attention"/>
  <result pre="treat skin infections, has recently received much attention for its" exact="antifungal" post="properties. Because of its lipophilic nature, which facilitates skin"/>
  <result pre="Hence, the purpose of this study was to evaluate the" exact="antifungal" post="activity of TTO and its main components against T."/>
  <result pre="whether TTO in association with ITZ or KTZ improves the" exact="antifungal" post="activity of these drugs against T. rubrum. 2. Results"/>
  <result pre="fungicidal concentration (MFC) results, TTO was found to display a" exact="fungicide" post="activity against T. rubrum isolates (Table 2). The two"/>
  <result pre="TTO and both azoles. The combinations of TTO with the" exact="antifungal" post="agents are reported in Table 3. By checkerboard testing,"/>
  <result pre="and both azoles. The combinations of TTO with the antifungal" exact="agents" post="are reported in Table 3. By checkerboard testing, the"/>
  <result pre="regression, and expensive, complex, and long-term therapy is often required." exact="Antifungal" post="drugs, such as azoles and terbinafine, play an important"/>
  <result pre="or resistance [12]. In fact, dermatophytes with low sensitivity to" exact="antifungal" post="drugs have occurred in many countries worldwide (i.e., Switzerland,"/>
  <result pre="in monotherapy, they can lead to adverse effects such as" exact="hepatotoxicity" post="[13]. In addition, terbinafine-resistant T. rubrum isolates sometimes showed"/>
  <result pre="Moreover, essential oils represent a class of phytonutrients with potential" exact="antimicrobial" post="and immunomodulatory capabilities [16]. TTO is an essential oil"/>
  <result pre="whether TTO in association with ITZ or KTZ improves the" exact="antifungal" post="activity of these azoles against T. rubrum. In this"/>
  <result pre="TTOs are known, according to ISO; however, most of the" exact="antimicrobial" post="activity could be related to chemotypes containing 30â€&quot;40% of"/>
  <result pre="to chemotypes containing 30â€&quot;40% of terpinen-4-ol [21]. Hence, the effective" exact="antifungal" post="activity of our chemotype against T. rubrum could be"/>
  <result pre="1). In fact, terpinen-4-ol was found to exhibit the strongest" exact="antifungal" post="effect against dimorphic fungi and yeasts, such as Saccharomyces"/>
  <result pre="strain [13,23]. Moreover, Pyun et al. [24] observed significant synergistic" exact="antifungal" post="activity when Allium sativum oil was combined with ketoconazole"/>
  <result pre="be explained by the essential oil promoting the effects of" exact="antifungal" post="drugs, mainly on the cell wall, plasma membrane, and"/>
  <result pre="TTO lowers the levels of the drug required to exert" exact="antifungal" post="actions. The essential oils damaging the cell wall and"/>
  <result pre="cell membrane destruction [8]. In this context, the mixture of" exact="antifungal" post="drugs is necessary to reach a better therapeutic action"/>
  <result pre="at 4 Â°C just before use [8,11]. 4.2. Reference as" exact="Antifungal" post="Agents ITZ and KTZ powders (â‰¥98% purity) were purchased"/>
  <result pre="a final inoculum of 1.5 Ã— 104 cfu/mL [28]. 4.4." exact="Antifungal" post="Susceptibility Testing In vitro susceptibility testing assays of TTO"/>
  <result pre="results. 5. Conclusions The limited range of conventional and effective" exact="antifungal" post="agents against Trichophyton spp. and the possible appearance of"/>
  <result pre="5. Conclusions The limited range of conventional and effective antifungal" exact="agents" post="against Trichophyton spp. and the possible appearance of unpleasant"/>
  <result pre="and therapeutic efficacy of the essential oil in combination with" exact="antifungal" post="drugs needs further in vitro and in vivo experiments."/>
  <result pre="Med. Biol.2016901172310.1007/5584_2015_501226566648 5.VaradrajP.GanavalliA.KikkeriN.N.Antifungal resistance in dermatologyIndian J. Dermatol.20186336136810.4103/ijd.IJD_131_1730210155 6.HadrichI.AyadiA.Epidemiology of" exact="antifungal" post="susceptibility: Review of literatureJ. Mycol. Med.20182857458410.1016/j.mycmed.2018.04.01129773435 7.MonodM.FeuermannM.SalaminK.FrattiM.MakinoM.AlshahniM.M.MakimuraK.YamadaeT.Trichophyton rubrum azole"/>
  <result pre="susceptible/not-susceptible Cryptococcus neoformans strainsBMC Complement. Altern. Med.20181814310.1186/s12906-018-2219-429724221 9.TullioV.RoanaJ.ScalasD.MandrasN.Evaluation of the" exact="antifungal" post="activity of Mentha x piperita (Lamiaceae) of Pancalieri (Turin,"/>
  <result pre="Tree Oil)2017Available online: https://www.iso.org/standard/69082.html(accessed on 2 February 2017) 21.BrunP.BernabÃ¨G.FilippiniR.PiovanA.In vitro" exact="antimicrobial" post="activities of commercially available Tea Tree (Melaleuca alternifolia) essential"/>
  <result pre="against dermatophytes and nondermatophytes, and in vitro evaluation of combination" exact="antifungal" post="activityBr. J. Dermatol.200314929630510.1046/j.1365-2133.2003.05418.x12932235 26.TamuraT.AsaharaM.YamamotoM.YamauraM.MatsumuraM.GotoK.Rezaei-MatehkolaeiA.MirhendiH.MakimuraM.MakimuraK.In vitro susceptibility of dermatomycoses agents"/>
  <result pre="combination antifungal activityBr. J. Dermatol.200314929630510.1046/j.1365-2133.2003.05418.x12932235 26.TamuraT.AsaharaM.YamamotoM.YamauraM.MatsumuraM.GotoK.Rezaei-MatehkolaeiA.MirhendiH.MakimuraM.MakimuraK.In vitro susceptibility of dermatomycoses" exact="agents" post="to six antifungal drugs and evaluation by fractional inhibitory"/>
  <result pre="J. Dermatol.200314929630510.1046/j.1365-2133.2003.05418.x12932235 26.TamuraT.AsaharaM.YamamotoM.YamauraM.MatsumuraM.GotoK.Rezaei-MatehkolaeiA.MirhendiH.MakimuraM.MakimuraK.In vitro susceptibility of dermatomycoses agents to six" exact="antifungal" post="drugs and evaluation by fractional inhibitory concentration index of"/>
  <result pre="29.collab: Clinical and Laboratory Standards InstituteReference Method for Broth Dilution" exact="Antifungal" post="Susceptibility Testing of Filamentous Fungi-Approved Standard, CLSI Document M38-A22nd"/>
 </snippets>
</snippetsTree>
